Neuroadaptive Changes in 5-HT1A Autoreceptor Sensitivity Following High-Dose MDMA Treatment
Simon David Fisher
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study |
|---|---|
| Population | Rats |
| Interventions | MDMA 8-OH-DPAT |
| Dose | MDMA: 4x 10 mg/kg i.p. at 2-hour intervals; 8-OH-DPAT: 0, 0.025, 0.05, 0.1 mg/kg s.c. (Experiment 2) and 0.0125 and 0.00625 mg/kg s.c. (Experiment 2b) |
| Duration | Two weeks between MDMA pretreatment and testing |
| Measures | 5-HTP accumulation, body temperature |
| Topics | MDMA Serotonin |
| Key findings | No significant changes in 5-HTP accumulation or hypothermic response to 8-OH-DPAT were found between MDMA-pretreated rats and controls, and no substantial serotonin deficits were observed. The authors conclude that the results do not indicate increased 5-HT1A autoreceptor sensitivity, but methodological issues prevent a firm conclusion. |
Abstract
Rationale: There is evidence that the serotonin (5-HT) deficits and related cognitive and mood impairments caused by +/-3,4- methylenedioxymethamphetamine (MDMA) may be mediated by neuroadaptations of the 5-HT1A autoreceptor.
Objectives: The increase in sensitivity of the 5-HT1A autoreceptor caused by highdose, repeated MDMA treatment was assessed neurochemically, by measuring 5- HTP accumulation, and physiologically, via changes in body temperature.
Methods: Experiment 1 confirmed the effects of 8-hydroxy-2-(di-npropylamino) tetralin (8-OH-DPAT) (0, 0.025, 0.05, 0.1 mg/kg s.c.) on 5- hydroxytryptophan (5-HTP) accumulation following 3-hydroxybenzylhydrazine dihydrochloride (NSD-1015) administration as a valid measure of 5-HT synthesis and hence 5-HT1A autoreceptor sensitivity in rats. Experiment 2 performed these procedures in additional animals, with half receiving MDMA (4x 10 mg/kg i.p. at 2 hour intervals) two weeks before testing. Body temperature changes due to the 8-OH-DPAT hypothermic response were tested using a rectal probe. Experiment 2b repeated the procedures in additional groups with lower doses of 8-OH-DPAT (0.0125 and 0.00625 mg/kg s.c.).
Results: No significant changes in 5-HTP accumulation levels or changes in the hypothermic response to 8-OH-DPAT were found between MDMA pretreated rats and controls in Experiments 2 and 2b. Moreover, there was no substantial evidence of expected 5-HT deficits due to high-dose MDMA treatment.
Conclusion: The results do not indicate an increase in sensitivity of the 5-HT1A autoreceptor, and hence the original hypothesis is not supported. However, there were a number of methodological issues, as indicated by the lack of MDMAinduced 5-HT deficits, which prevent a firm conclusion from being drawn. Future research is outlined to overcome these issues.
Comparable studies
Other preclinical and animal studies on MDMA, most cited first.
Citations in the library
Cites 57
- The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology July 19, 2010
- Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings The Lancet October 1, 1998
- Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity Journal of Neuroscience August 1, 1988
- Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. Journal of Pharmacology and Experimental Therapeutics 1987
- Memory impairment in abstinent MDMA ("Ecstasy") users Neurology December 1, 1998
and 52 more in the library